Reactive Airway Disease and the Management of Samter’s Triad

  • Roxanne S. Leung
  • Rohit K. Katial
  • Todd T. Kingdom

It has become increasingly clear that respiratory inflammation affects both the upper and lower airways. Recent investigation has established both epidemiologic and pathophysiological links between allergic rhinitis (AR), chronic rhinosinusitis (CRS), chronic rhinosinusitis with nasal polyposis (CRSwNP), and asthma. Physicians who frequently diagnose and manage patients with upper airway diseases, such as AR and CRS, encounter patients with asthma or concurrent lower respiratory disease. Conversely, physicians primarily addressing lower airway diseases encounter patients with significant sinonasal diseases that may be quite relevant to the patients’ overall conditions. Physicians such as family medicine specialists, pulmonary specialists, allergists, internists, and otolaryngologists must design treatment protocols, and expectations, based on this current understanding of the role that respiratory inflammation plays in the development of upper and lower airways diseases.

Patients with...


Allergic Rhinitis Allergic Rhinitis Nasal Polyp Lower Airway Endoscopic Sinus Surgery 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Stevenson DD, Szczeklik A. Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol 2006; 118:773–786.PubMedCrossRefGoogle Scholar
  2. 2.
    National Health Interview Survey, National Center for Health Statistics, Centers for Disease Control and Prevention, 2005. Available at Accessed August 1, 2007.
  3. 3.
    Allergies in America: a landmark survey of nasal allergy sufferers. Available at: Accessed August 1, 2007.
  4. 4.
    Simons FER. Allergic rhinobronchitis: the asthma-allergic rhinitis link. J Allergy Clin Immunol 1999;104:534–540.PubMedCrossRefGoogle Scholar
  5. 5.
    Peat JK, Salome CM, Woolcock AJ. Longitudinal changes in atopy during a 4-year period: relation to bronchial hyperresponsiveness and respiratory symptoms in a population sample of Australian schoolchildren. J Allergy Clin Immunol 1989;85:65–74.CrossRefGoogle Scholar
  6. 6.
    Settipane RJ, Hagy GW, Settipane GA. Long-term risk factors for developing asthma and allergic rhinitis: a 23 year follow-up study of college students. Allergy Proc 1994;15:21–25.PubMedCrossRefGoogle Scholar
  7. 7.
    Leynaert B, Bousquet J, Neukirch, et al. Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects. J Allergy Clin Immunol 1999;104:301–304.PubMedCrossRefGoogle Scholar
  8. 8.
    Fotanari P, Burnet H, Zattara-Hartmann MC, et al. Changes in airway resistance induced by nasal inhalation of cold dry, dry, or moist air in normal individuals. J Appl Physiol 1996;81:1739–1743.Google Scholar
  9. 9.
    Gerblich AA, Schwartz HJ, Chester EH. Seasonal variation of airway function in allergic rhinitis. J Allergy Clin Immunol 1986;77:676–681.PubMedCrossRefGoogle Scholar
  10. 10.
    Corren J, Adinoff AD, Irvin CG. Changes in bronchial responsiveness following nasal provocation with allergen. J Allergy Clin Immunol 1992;89:611–618.PubMedCrossRefGoogle Scholar
  11. 11.
    Bardin PG, Van Heerden MMB, Jourbert JR. Absence of pulmonary aspiration of sinus contents in patients with asthma and sinusitis. J Allergy Clin Immunol 1990;86:82–88.PubMedCrossRefGoogle Scholar
  12. 12.
    Chanez P, Vignola AM, Vic P, et al. Comparison between nasal and bronchial inflammation in asthmatic and control subjects. Am J Respir Crit Care Med 1999;159:588–595.PubMedGoogle Scholar
  13. 13.
    Henriksen JM, Wenzel A. Effect of an intranasally administered corticosteroid (budesonide) on nasal obstruction, mouth breathing, and asthma. Am Rev Respir Dis 1984;130: 1014–1018.PubMedGoogle Scholar
  14. 14.
    Welsh PW, Stricker WE, Chu CP, et al. Efficacy of beclomethasone nasal solution, flunisolide, and cromolyn in relieving symptoms of ragweed allergy. Mayo Clin Proc 1987;62:125–134.PubMedGoogle Scholar
  15. 15.
    Forensi A, Pelucchi A, Gherson G, et al. Once daily intranasal fluticasone proprionate (220 mcg) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis. J Allergy Clin Immunol 1996;98:274–282.CrossRefGoogle Scholar
  16. 16.
    Watson WTA, Becker A, Simons ER. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness. J Allergy Clin Immunol 1993; 91:97–101.PubMedCrossRefGoogle Scholar
  17. 17.
    Adams RJ, Fuhlbigge A, Finkelstein JA, et al. Intranasal steroids and the risk of emergency department visits for asthma. J Allergy Clin Immunol 2002;109:636–642.PubMedCrossRefGoogle Scholar
  18. 18.
    Greiff L, Andersson M, Svensson C, et al. Effects of orally inhaled budesonide in seasonal allergic rhinitis. Eur Respir J 1998;11:1268–1273.PubMedCrossRefGoogle Scholar
  19. 19.
    Moller C, Dreborg S, Ferdousi H, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-Study). J Allergy Clin Immunol 2002;109:251–256.PubMedCrossRefGoogle Scholar
  20. 20.
    Valovirta E, Jacobsen L, Niggemann B, et al. A 3-year course of subcutaneous specific immunotherapy results in long-term prevention of asthma in children. Ten-year follow-up on the PAT-study. J Allergy Clin Immunol 2006;117:721.CrossRefGoogle Scholar
  21. 21.
    Samter M, Beers RF. Intolerance to aspirin. Ann Intern Med 1968;68:975–983.PubMedGoogle Scholar
  22. 22.
    Jenkins C, Costello J, Hodge L. Systemic review of prevalence of aspirin-induced asthma and its implications for clinical practice. BMJ 2004;328:434–437.PubMedCrossRefGoogle Scholar
  23. 23.
    Sanak M, Simon H-U, Szczeklik A. Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet 1997;350:599–600.CrossRefGoogle Scholar
  24. 24.
    Van Sambeek R, Stevenson DD, Baldsaro M, et al. 5’-Flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States. J Allergy Clin Immunol 2000;106:72–76.PubMedCrossRefGoogle Scholar
  25. 25.
    Drazen JM. Leukotrienes as mediators of airway obstruction. Am J Respir Crit Care Med 1998;158:S193–S200.PubMedGoogle Scholar
  26. 26.
    Sanak M, Kielbasa B, Bochenek G, et al. Exhaled eicosanoids following oral aspirin challenge in asthmatic patients. Clin Exp Allergy 2004;34:1899–1904.PubMedCrossRefGoogle Scholar
  27. 27.
    Sousa AR, Parikh A, Scadding G, et al. Leukotriene-receptor expression on nasalmucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med 2002;347:1493–1499.PubMedCrossRefGoogle Scholar
  28. 28.
    Sestini P, Armetti L, Gambaro G, et al. Inhaled PGE2 prevents aspirin induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma. Am J Respir Crit Care Med 1996;153:572–575.PubMedGoogle Scholar
  29. 29.
    Pujols L, Mullol J, Alobid I, et al. Dynamics of COX-2 in nasal mucosa and nasal polyps from aspirin-tolerant and aspirin-intolerant patients with asthma. J Allergy Clin Immunol 2004;114:814–819.PubMedCrossRefGoogle Scholar
  30. 30.
    Mullol J, Fernandez-Morata JC, Roca-Ferrer J, et al. Cyclooxygenase 1 and cyclooxygenase 2 expression is abnormally regulated in human nasal polyps. J Allergy Clin Immunol. 2002;109:824–830.PubMedCrossRefGoogle Scholar
  31. 31.
    Owens J, Shroyer K, Kingdom TT. Expression of cyclooxygenase and lipoxygenase enzymes in nasal polyps of aspirin sensitive and aspirin tolerant patients. Arch Otolaryngol Head Neck Surg 2006;132:579–587.PubMedCrossRefGoogle Scholar
  32. 32.
    Simon RA. Treatment of patients with respiratory reactions to aspirin and nonsteroidal anti-inflammatory drugs. Curr Allergy Asthma Rep 2004;4:139–143.PubMedCrossRefGoogle Scholar
  33. 33.
    Settipane RA, Shrank PJ, Simon RA, et al. Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects. J Allergy Clin Immunol 1995;96:480–485.PubMedCrossRefGoogle Scholar
  34. 34.
    Dahlen B, Nizankowska E, Szczeklik A, et al. Benefits from adding the 5-lipoxygenase Inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. Am J Respir Crit Care Med 1998;157:1187–1194.PubMedGoogle Scholar
  35. 35.
    Parnes SM, Chuma AV. Acute effects of antileukotrienes on sinonasal polyposis and sinusitis. Ear Nose Throat J 2000;79:18–20.PubMedGoogle Scholar
  36. 36.
    Ragab S, Parikh A, Darby YC, et al. An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma. Clin Exp Allergy 2001;31:1385–1391.PubMedCrossRefGoogle Scholar
  37. 37.
    Macy E, Berstein JA, Castells MC, et al. Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper. Ann Allergy Asthma Immunol. 2007;98:172–174.PubMedCrossRefGoogle Scholar
  38. 38.
    Pleskow WW, Stevenson DD, Mathison DA, et al. Aspirin desensitization in aspirin sensitive asthmatic patients: clinical manifestations and characterization of the refractory period. J Allergy Clin Immunol 1982;69:11–19.PubMedCrossRefGoogle Scholar
  39. 39.
    White A, Stevenson D, Simon R. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 2005;95:330–335.PubMedCrossRefGoogle Scholar
  40. 40.
    Berges-Gimeno MP, Simon RA, Stevenson DD. The effect of leukotriene-modifier drugs on aspirin-induced asthma and rhinitis reactions. Clin Exp Allergy 2002;32:1491–1496.PubMedCrossRefGoogle Scholar
  41. 41.
    Berges-Gimeno MP, Simon RA, Stevenson DD. Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2003;111:180–186.PubMedCrossRefGoogle Scholar
  42. 42.
    Levine HL. Functional endoscopic sinus surgery: evaluation, surgery, and follow-up of 250 patients. Laryngoscope 1990;100:79–83.PubMedGoogle Scholar
  43. 43.
    Kennedy DW. Prognostic factors, outcomes, and staging in ethmoid sinus surgery. Laryngoscope 1992;102:1–18.PubMedGoogle Scholar
  44. 44.
    Senior BA, Kennedy DW, Tanabodee J, et al. Long-term results of functional endoscopic sinus surgery. Laryngoscope 1998;108:151–157.PubMedCrossRefGoogle Scholar
  45. 45.
    Metson RB, Gliklich RE. Clinical outcomes in patients with chronic sinusitis. Laryngoscope 2000;110(suppl 94):24–28.PubMedCrossRefGoogle Scholar
  46. 46.
    Poetker DM, Smith TL. Adult chronic rhinosinusitis: surgical outcomes and the role of endoscopic sinus surgery. Curr Opin Otolaryngol Head Neck Surg 2007;15:6–9.PubMedCrossRefGoogle Scholar
  47. 47.
    Banerji A, Piccirillo JF, Thawley SE, et al. Chronic rhinosinusitis patients with polyps or polypoid mucosa have a greater burden of illness. Am J Rhinol 2007;21:19–26.PubMedCrossRefGoogle Scholar
  48. 48.
    Smith TL, Mendolia-Loffredo S, Loehrl TA, et al. Predictive factors and outcomes in endoscopic sinus surgery for chronic rhinosinusitis. Laryngoscope 2005;115:2199–2205.PubMedCrossRefGoogle Scholar
  49. 49.
    Ragab SM, Lund VJ, Scadding G. Evaluation of the medical and surgical treatment of chronic rhinosinusitis: a prospective, randomized, controlled trial. Laryngoscope 2004;114: 923–930.PubMedCrossRefGoogle Scholar
  50. 50.
    Poetker DM, Mendolia-Loffredo S, Smith TL. Outcomes of endoscopic sinus surgery for chronic rhinosinusitis associated with sinonasal polyposis. Am J Rhinol 2007;21:84–88.PubMedCrossRefGoogle Scholar
  51. 51.
    Nishioka GJ, Cook PR, Davis WE, et al. Functional endoscopic sinus surgery in patients with chronic sinusitis and asthma. Otolaryngol Head Neck Surg 1994;110:494–500.PubMedGoogle Scholar
  52. 52.
    Palmer JN, Conley DB, Dong RG, et al. Efficacy of endoscopic sinus surgery in the management of patients with asthma and chronic sinusitis. Am J Rhinol 2001;15:49–53.PubMedCrossRefGoogle Scholar
  53. 53.
    Senior BA, Kennedy DW, Tanabodee J, et al. Long-term impact of functional endoscopic sinus surgery on asthma. Otolaryngol Head Neck Surg 1999;121:66–68.PubMedCrossRefGoogle Scholar
  54. 54.
    Dhong HJ, Jung YS, Chung SK, et al. Effect of endoscopic sinus surgery on asthmatic patients with chronic rhinosinusitis. Otolaryngol Head Neck Surg 2001;124:99–104.PubMedCrossRefGoogle Scholar
  55. 55.
    Goldstein MF, Grundfast SK, Dunsky EH, et al. Effect of functional endoscopic sinus surgery on bronchial asthma outcomes. Arch Otolaryngol Head Neck Surg 1999;125:314–319.PubMedGoogle Scholar
  56. 56.
    Ragab S, Scadding GK, Lund VJ, et al. Treatment of chronic rhinosinusitis and its effects on asthma. Eur Respir J 2006;28:68–74.PubMedCrossRefGoogle Scholar
  57. 57.
    Nakamura H, Kawasaki M, Higuchi Y, et al. Effects of sinus surgery on asthma in aspirin triad patients. Acta Otolaryngol (Stockh) 1999;119:592–598.CrossRefGoogle Scholar
  58. 58.
    McFadden EA, Woodson BT, Fink JN, et al. Surgical management of aspirin triad sinusitis. Am J Rhinol 1997;11:263–270.PubMedCrossRefGoogle Scholar
  59. 59.
    Amar YG, Frenkiel S, Sobol SE. Outcome analysis of ESS for chronic sinusitis in patients having Samter’s triad. J Otolaryngol 2000;29:7–12.PubMedGoogle Scholar
  60. 60.
    Batra PS, Kern RC, Tripathi A, et al. Outcome analysis of ESS in patients with nasal polyps and asthma. Laryngoscope 2003;113:1703–1706.PubMedCrossRefGoogle Scholar
  61. 61.
    Robinson JL, Griest S, James KE, et al. Impact of aspirin intolerance on outcomes of sinus surgery. Laryngoscope 2007;117:825–830.PubMedCrossRefGoogle Scholar
  62. 62.
    Loehrl TA, Ferre RM, Toohill RJ, et al. Long-term asthma outcomes after endoscopic sinus surgery in aspirin triad patients. Am J Otolaryngol Head Neck Med Surg 2006;27:154–160.Google Scholar
  63. 63.
    Francis C. The prognosis of operations of nasal polypi in cases of asthma. Practitioner 1928;123:272–278.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Roxanne S. Leung
  • Rohit K. Katial
  • Todd T. Kingdom
    • 1
  1. 1.Department of OtolaryngologyUniversity of Colorado Health Sciences CenterAuroraUSA

Personalised recommendations